<?xml version="1.0" encoding="UTF-8"?>
<ref id="B122-pharmaceutics-13-00387">
 <label>122.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>De Goede</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Boedhram</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Eckhardt</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Hanff</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Koch</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Vermaat</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Vermes</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Development and validation of a paediatric oral formulation of clonidine hydrochloride</article-title>
  <source>Int. J. Pharm.</source>
  <year>2012</year>
  <volume>433</volume>
  <fpage>119</fpage>
  <lpage>120</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ijpharm.2012.04.055</pub-id>
  <?supplied-pmid 22580108?>
  <pub-id pub-id-type="pmid">22580108</pub-id>
 </element-citation>
</ref>
